These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3042314)
1. Use of NovoPen in diabetic patients on CAPD. Van Crombrugge P Diabetes Care; 1988 Apr; 11(4):373-4. PubMed ID: 3042314 [No Abstract] [Full Text] [Related]
6. Administration of insulin by continuous ambulatory peritoneal dialysis. Chan E; Montgomery PA Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911 [TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal insulin: new alternative for diabetic CAPD patients. Bandel-Walcer R; Myers C; Malgaonkar S; Lyman N AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191 [No Abstract] [Full Text] [Related]
8. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. Quellhorst E J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768 [TBL] [Abstract][Full Text] [Related]
9. Hepatic subcapsular steatosis in diabetic CAPD patients treated with intraperitoneal insulin. Description of a typical pattern. Kallio T; Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A Acta Radiol; 2001 May; 42(3):323-5. PubMed ID: 11350293 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis]. Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332 [No Abstract] [Full Text] [Related]
11. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin. Grefberg N; Danielson BG; Berne C J Diabet Complications; 1987; 1(1):16-9. PubMed ID: 2968990 [TBL] [Abstract][Full Text] [Related]
12. Insulin prescription, glycemic control, and diabetic complications in diabetics treated by continuous ambulatory peritoneal dialysis. Rottembourg J; Issad B; Allouache M Perit Dial Int; 1993; 13 Suppl 2():S232-5. PubMed ID: 8399575 [No Abstract] [Full Text] [Related]
13. Insulin absorption from the peritoneal cavity. Zingg W; Leibel BS Life Support Syst; 1985; 3(4):335-42. PubMed ID: 3906287 [No Abstract] [Full Text] [Related]
14. Education and care of the diabetic patient on CAPD. Stephenson E; Nordberg T Diabetes Educ; 1983; 9(1):17-9. PubMed ID: 6341020 [No Abstract] [Full Text] [Related]
15. Insulin influence (used as an additive to dialysate) on the mitogenic-induced effect of the peritoneal effluent in CAPD patients. Selgas R; Lopez-Rivas A; Alvaro F; Tarduchy GR; Rueda P; Muñoz J; Vara F Adv Perit Dial; 1989; 5():161-4. PubMed ID: 2577403 [TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD. Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993 [No Abstract] [Full Text] [Related]
18. Successful pregnancy in a diabetic patient treated with continuous ambulatory peritoneal dialysis. Kioko EM; Shaw KM; Clarke AD; Warren DJ Diabetes Care; 1983; 6(3):298-300. PubMed ID: 6872812 [TBL] [Abstract][Full Text] [Related]
19. A potential hazard of U 100 insulin syringes in diabetic on CAPD. Fisher J; Wilson JM; Walls J Lancet; 1983 Dec; 2(8363):1363. PubMed ID: 6139692 [No Abstract] [Full Text] [Related]
20. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients. Nevalainen P; Lahtela JT; Mustonen J; Pasternack A Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]